Alisia Cesta
Impact in
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
- Ovarian function and disorders
-
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Cancer Risks and Factors
- Cancer Treatment and Pharmacology
Papers in
- Co-authors
- F. Recchia (19 shared papers)Silvio Rea (18 shared papers)Gaetano Saggio (15 shared papers)Giampiero Candeloro (14 shared papers)Anna Di Blasio (9 shared papers)Antonio Nuzzo (5 shared papers)Stefano Necozione (8 shared papers)G Carta (3 shared papers)
In The Last Decade
Alisia Cesta
20 papers receiving 323 citations
Peers
Comparison fields: 5 of 46
- Reproductive Medicine 65
- Oncology 141
- Public Health, Environmental and Occupational Health 75
- Immunology 46
- Pulmonary and Respiratory Medicine 47
Countries citing papers authored by Alisia Cesta
This map shows the geographic impact of Alisia Cesta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alisia Cesta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alisia Cesta more than expected).
Fields of papers citing papers by Alisia Cesta
This network shows the impact of papers produced by Alisia Cesta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alisia Cesta. The network helps show where Alisia Cesta may publish in the future.
Co-authors
The 25 scholars most cited alongside Alisia Cesta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 97 | |
| 2 | 2005 | 40 | |
| 3 | 2005 | 27 | |
| 4 | 2006 | 23 | |
| 5 | 2005 | 23 | |
| 6 | Phase 1B study of subcutaneously administered interleukin 2 in combination with 13-cis retinoic acid as maintenance therapy in advanced cancer. | 2001 | 23 |
| 7 | 2007 | 19 | |
| 8 | 2003 | 18 | |
| 9 | Phase II randomized study of interleukin-2 with or without 13-cis retinoic acid as maintenance therapy in patients with advanced cancer responsive to chemotherapy. | 2005 | 16 |
| 10 | 2004 | 12 | |
| 11 | 2007 | 10 | |
| 12 | 2006 | 7 | |
| 13 | 2007 | 6 | |
| 14 | Paclitaxel plus gemcitabine in advanced non-small cell lung cancer patients with low performance status. | 2005 | 5 |
| 15 | 2013 | 4 | |
| 16 | 2008 | 3 | |
| 17 | Dose-finding study of docetaxel added to ifosfamide and cisplatin followed by concomitant capecitabine and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck. | 2006 | 3 |
| 18 | 2013 | 1 | |
| 19 | 2014 | 1 | |
| 20 | 2006 | 1 |
About Alisia Cesta
Alisia Cesta is a scholar working on Oncology, Surgery, Molecular Biology, Pulmonary and Respiratory Medicine and Immunology, having authored 20 papers that have together received 339 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (4 papers), Retinoids in leukemia and cellular processes (3 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer Treatment and Pharmacology (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Breast Cancer Treatment Studies (2 papers), Immune Cell Function and Interaction (2 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Reproductive Medicine (65 citations), Oncology (141 citations), Public Health, Environmental and Occupational Health (75 citations), Immunology (46 citations) and Pulmonary and Respiratory Medicine (47 citations). Alisia Cesta has collaborated with scholars based in Italy, Colombia and Iran. Frequent co-authors include F. Recchia, Silvio Rea, Gaetano Saggio, Giampiero Candeloro, Anna Di Blasio, Antonio Nuzzo, Stefano Necozione, G Carta, Edoardo Alesse and Marco Lombardo. Their work appears in journals such as Journal of Immunotherapy, Anti-Cancer Drugs, Journal of Clinical Oncology, International Journal of Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.